Report
Asia-Pacific Conjugate Vaccine Market (2018-2023)
  • Publish Date: May-2022
  • Report Code: QI042
  • Price: $ 1800/-

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Asia Pacific is the fastest growing market for conjugate vaccines. The conjugate vaccines market in Asia-Pacific is expected to expand at a CAGR of 23.5%, leading...

Read More
China Conjugate Vaccine Market (2018-2023)
  • Publish Date: May-2022
  • Report Code: QI042
  • Price: $ 1800/-

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. China is one of the prominent markets with a significant growth rate for conjugate vaccines. All Expanded Program on Immunization (EPI) vaccines (including tuberculosis, polio, measles,...

Read More
Japan Conjugate Vaccine Market (2018-2023)
  • Publish Date: May-2022
  • Report Code: QI042
  • Price: $ 1800/-

Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. Japan is one of the most prominent markets of conjugate vaccines. Japan, at 84 years, has one of the highest life expectancies in the world. Currently,...

Read More
EU5 Conjugate Vaccine Market (2018-2023)
  • Publish Date: May-2022
  • Report Code: QI042
  • Price: $ 1800/-

Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. EU5 is one of the most prominent markets for conjugate vaccines. The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program...

Read More